Market may have misinterpreted recent rare earth events, says Canaccord Genuity’s George GianarikasNovember 7, 2025
Market may have misinterpreted recent rare earth events, says Canaccord Genuity’s George GianarikasNovember 7, 2025
There’s a fear OpenAI is playing a race to becoming too big to fail, says Slow Ventures’ Sam LessinNovember 7, 2025
Share Facebook Twitter LinkedIn Pinterest Email Will Lewis, Insmed CEO, joins ‘Fast Money’ to discuss the company’s lung drug being greenlit by the FDA and what it means for for the stock.
